Lindsay Janes
Plastic and Reconstructive Surgery · Chicago, ILNPI 1740675446
Payments from drug & device makers
What this record shows
This record is dominated by grants: $12,500 of the $13,662 with a category attached, or 91.5%. Kls-martin L.p. accounts for 91.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $12,500 and has fallen 96.4% since, to $452 in 2025.
Across 20 payments — averaging $683.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$13K
- Acera Surgical, Inc.$323
- AbbVie$278
- Integra Lifesciences Corporation$156
- Polynovo North America LLC$121
- Stryker$68
- plus $215 from 7 others
What the payments were for
- Grants$12,50091%
- Food & beverage$1,1629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 2 | $12,500 |
| Acera Surgical, Inc. | 3 | $323 |
| AbbVie(2 entities) | 3 | $278 |
| Integra Lifesciences Corporation | 3 | $156 |
| Polynovo North America LLC | 1 | $121 |
| Stryker | 1 | $68 |
| Alnylam Pharmaceuticals Inc. | 1 | $68 |
| Paladin Technology Solutions | 1 | $37 |
| Solventum Corporation | 1 | $33 |
| Davol Inc. | 1 | $29 |
| Motiva USA, LLC | 1 | $21 |
| KCI USA, Inc. | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,662 in reported general payments places this provider in the 85th percentile of 126 plastic and reconstructive surgery providers in Illinois.
See all plastic and reconstructive surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Chicago
- John KimChicago$7.3M
- Julius FewChicago$148K
- Gregory DumanianChicago$50K
- Stefan SzczerbaChicago$29K
- Amir DorafsharChicago$29K
- Michael HornChicago$14K
- Georgios KokosisChicago$13K
- Cristin CoquillardChicago$13K
- Brian BraithwaiteChicago$12K
- Kevin YangChicago$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.